June 19, 2024
CPDD provides a national and international forum for scientists of diverse backgrounds to advance the understanding of molecular-neurobiological aspects of addictive disorders and, by the application of new scientific knowledge, to improve and develop treatments utilizing novel behavioral and pharmacological therapies. Since 1938, a major focus of the CPDD’s activities has been its sponsorship of an annual scientific meeting. This conference serves as a forum bringing together basic scientists and clinical investigators from industry, academia, and government. Representatives of regulatory agencies, as well as scientists and professionals in a number of diverse disciplines interested in the biochemical, behavioral, and public health aspects of drug dependence participate.
Symposium: Innovations in Digital Interventions for Substance Use
Chair: Inbal Nahum-Shani, University of Michigan
Co-Chair: Lisa Marsch, Geisel School of Medicine at Dartmouth
The rapid growth, affordability and acceptability of digital technologies can revolutionize behavioral interventions for substance use. Modern technologies such as electronic health records (EHRs), telehealth, and mobile devices can facilitate greater access, scalability, and impact. Powerful mobile and sensing technologies can be harnessed to deliver just-in-time adaptive interventions (JITAIs)—interventions that use dynamically changing information about the individual’s internal state (e.g., craving, stress), and context (e.g., physical location) to recommend whether and how to deliver interventions in real time, in the individual’s natural environment, while minimizing participant effort, burden and habituation. Innovations in artificial intelligence (AI) offer opportunities to further personalize intervention delivery by continually interacting with each participant and learning how to best adapt the intervention to their changing needs as they experience the intervention in real time. This symposium highlights four NIH/NIDA-funded pilot projects, each using digital technologies to build cutting-edge interventions for substance use. The first project focuses on developing a digital intervention to address co-occurring disorders—substance use and depression; the second focuses on designing a digital opioid safety educational intervention that meets patient needs while addressing implementation barriers experienced by pharmacist; the third project 56ABSTRACTS concerns the development of a dyadic JITAI for improving parent-child relationships and reducing substance use; and the fourth project employs AI algorithms to increase mobile health engagement and reduce substance use in real-time. Opportunities and challenges for leveraging advances in digital technologies to prevent and treat substance use will be discussed.
Development of a Digital Intervention for Positive Valence System Dysfunction in CoOccurring Depression and Cannabis Use
Amanda Collins, Dartmouth College
Development and Initial Testing of a Pilot Pharmacy-Based Digital Opioid Safety Intervention
Deepika Rao, Dartmouth College
Parents and Teens Together (PATT): Developing a Dyadic Digital Intervention to Prevent SUDs
Amy Hughes Lansing, University of Vermont
Development of a Personalized Just-In-Time Adaptive Intervention for Emerging Adults With Regular Cannabis Use
Lara Coughlin, University of Michigan
Keep up to date with the latest news, events, software releases, learning modules, and resources from the d3center.
© 2025 • d3center • Institute for Social Research • University of Michigan